(Q51487611)

5 April 2018

title

Poly(ADP-ribose) polymerase-1 (PARP-1) pharmacogenetics, activity and expression analysis in cancer patients and healthy volunteers. (English)

1 reference

5 April 2018

author name string

Tomasz Zaremba

1

1 reference

5 April 2018

Huw D Thomas

2

1 reference

5 April 2018

Michael Cole

3

1 reference

5 April 2018

Sally A Coulthard

4

1 reference

5 April 2018

Elizabeth R Plummer

5

1 reference

5 April 2018

Nicola J Curtin

6

1 reference

5 April 2018

language of work or name

English

0 references

publication date

1 June 2011

1 reference

5 April 2018

published in

Biochemical Journal

1 reference

5 April 2018

volume

436

1 reference

5 April 2018

issue

3

1 reference

5 April 2018

page(s)

671-679

1 reference

5 April 2018

Poly(ADP-ribose) polymerase and the therapeutic effects of its inhibitors

cites work

1 reference

https://api.crossref.org/works/10.1042%2FBJ20101723

The therapeutic potential of poly(ADP-ribose) polymerase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20101723

The ADPRT V762A genetic variant contributes to prostate cancer susceptibility and deficient enzyme function

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20101723

Temozolomide pharmacodynamics in patients with metastatic melanoma: dna damage and activity of repair enzymes O6-alkylguanine alkyltransferase and poly(ADP-ribose) polymerase-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20101723

Increased poly(ADP-ribose) polymerase activity in lymphoblastoid cell lines from centenarians

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20101723

Dinucleotide repeat polymorphism at the human poly (ADP-ribose) polymerase gene (PPOL)

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20101723

Poly(ADP-ribosyl)ation of transcription factor Yin Yang 1 under conditions of DNA damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20101723

Transcription factor Yin Yang 1 stimulates poly(ADP-ribosyl)ation and DNA repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20101723

Association between polymorphisms in DNA base excision repair genes XRCC1, APE1, and ADPRT and differentiated thyroid carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20101723

Poly(ADP-ribose) polymerase activity in mononuclear leukocytes of 13 mammalian species correlates with species-specific life span

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20101723

Phase I study of the poly(ADP-ribose) polymerase inhibitor, AG014699, in combination with temozolomide in patients with advanced solid tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20101723

Oral poly(ADP-ribose) polymerase-1 inhibitor BSI-401 has antitumor activity and synergizes with oxaliplatin against pancreatic cancer, preventing acute neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20101723

Poly(ADP-ribose) polymerase-1 polymorphisms, expression and activity in selected human tumour cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20101723

New polymorphisms in the human poly(ADP-ribose) polymerase-1 coding sequence: lack of association with longevity or with increased cellular poly(ADP-ribosyl)ation capacity

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20101723

Genetic sequence variations and ADPRT haplotype analysis in French Canadian families with high risk of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20101723

Gender differences in the endotoxin-induced inflammatory and vascular responses: potential role of poly(ADP-ribose) polymerase activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20101723

Novel modulators of poly(ADP-ribose) polymerase

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20101723

Sex differences in the response to activation of the poly (ADP-ribose) polymerase pathway after experimental stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20101723

Poly (ADP-ribose) polymerase-1 initiated neuronal cell death pathway--do androgens matter?

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20101723

Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20101723

Poly(ADP)-ribose polymerase inhibition: frequent durable responses in BRCA carrier ovarian cancer correlating with platinum-free interval

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20101723

A prospective study on lung toxicity in patients treated with gemcitabine and carboplatin: clinical, radiological and functional assessment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20101723

Patient perceptions about chemotherapy-induced oral mucositis: implications for primary/secondary prophylaxis strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20101723

A poly(ADP-ribose) polymerase haplotype spanning the promoter region confers susceptibility to rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20101723

21 January 2018

Identifiers

DOI

10.1042/BJ20101723

1 reference

5 April 2018

1 reference

5 April 2018